+ 1.99
+ 0.61%
+ 0.57
+ 0.18%
+ 0.88
+ 0.23%

Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week

September 9, 2019 9:09 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week

Cannabis Countdown: Top 10 Marijuana Stock News Stories of the Week

Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 marijuana stock news stories for the week of September 2nd – 8th, 2019.

Without further ado, let’s get started.

10. Bank of Montreal Isn’t Letting Retail Investors Short Cannabis Stocks Anymore

Bank of Montreal (BMO) retail investors that use BMO’s self-directed online discount brokerage may have noticed something different with the platform recently. According to multiple retail investors, BMO’s InvestorLine online brokerage is no longer allowing them to short cannabis stocks in their accounts.

While on the institutional side, it’s business as usual.

Read full BMO article

9. Word on the Street Says Tilray is in Talks with Big Tobacco, But is it True?

After briefly reaching a new 52-week low this morning, shares of Tilray Inc (NASDAQ:TLRY) rebounded sharply today fueled by circulating rumours that the Canadian licensed producer (LP) was in talks with a large tobacco company.

According to an unknown source, Tilray is nearing a deal with an unnamed tobacco firm which would see them take a large equity stake in the LP.

Read full Tilray article

8. CannTrust Holdings Cuts 20% of Workforce

Canntrust Holdings (TSX:TRST) (NYSE:CTST) announced this evening that it will be reducing its workforce significantly as a result of its ongoing troubles at both its Pelham, Ontario, and Vaughan, Ontario facilities.

The move impacts 180 employees at the company, or roughly 20% of its entire workforce.

Read full CannTrust article

7. TruTrace: Aphria Joins Phase 2 of Shoppers Drug Mart Medical Cannabis Verification Program

TruTrace Technologies (CSE:TTT) (OTCQB:TTTSF) announced Thursday that Aphria Inc (TSX:APHA) (NYSE:APHA) has joined Phase 2 of the Shoppers Drug Mart medical cannabis verification pilot program.

TruTrace’s blockchain-secured program is specifically designed to increase transparency, interoperability and product identification within the medical cannabis industry.

Read full Aphria article

6. Aurora Cannabis Dumps Remaining Stake in TGOD for $86.5 Million

The relationship between Aurora Cannabis (TSX:ACB) (NYSE:ACB) and The Green Organic Dutchman (TSX:TGOD) (OTCQX:TGODF) has officially come to an end.

This morning, it was reported that Aurora sold its remaining position in TGOD for gross proceeds $86.5 million.

Read full ACB/TGOD article

Source: Shutterstock

5. Aleafia Health Extends Lead in the Race for Outdoor Cannabis Supremacy

Aleafia Health (TSX:ALEF) (OTCQX:ALEAF), the leader of the Canadian outdoor cannabis space announced this morning it has increased its lead over the other three top outdoor players WeedMD (TSXV:WMD) (OTCQX:WDDMF), 48North (TSXV:NRTH) (OTCPK: NCNNF), and CannTrust (TSX:TRST) (NYSE:CTST).

In addition to Aleafia’s acquisition of 60 acres of land, the company’s wholly-owned subsidiary Emblem closed on the sale of surplus land for $8.2 million in cash.

Read full Aleafia article

4. Cronos Group Closes Lord Jones Acquisition

In the latest of a series of acquisitions by marijuana stocks, Canada’s Cronos Group (TSX:CRON) (NASDAQ:CRON) has wrapped up its most recent asset buy.

Cronos agreed to buy the subsidiaries last month in a move that gave it control of the upscale Lord Jones brand of cannabidiol (CBD)-based beauty care products. Cronos is paying around $300 million for the subsidiaries.

Read full Cronos article

3. Canopy CEO Eyes ‘Big Prize’ Ahead of Legal Edibles

As Canopy Growth Inc (TSX:WEED) (NYSE:CGC) searches for a new chief executive officer, its current boss is staying focused on the next wave of cannabis products set to hit the market.

“We need to see more stores come online and we need to see the value-add ‘Cannabis 2.0’ products come in,” said Mark Zekulin, Canopy Growth’s CEO, during an interview with BNN Bloomberg on Thursday.

Read full Canopy Edibles article

2. Trump’s Pot Remarks Spark Hope for Canopy Growth’s U.S. Acquisition, say CEOs

The chief executives of Canopy Growth (TSX:WEED) (NYSE:CGC) and Acreage Holdings (CSE:ACRG) (OTCQX:ACRGF) are encouraged by growing support for cannabis reform in the United States, developments that could pave the way for Canopy becoming the largest player in the massive American market.

“Most large groups you talk to, whether Democrat or Republican, or American farmers, are in favour of state’s rights progressing. I think that is a major step in the right direction,” said Canopy Growth CEO Mark Zekulin.

Read full Trump/Canopy article

1. Cannabis Stocks Heat Up in Anticipation of Canada’s Legalization 2.0, Has the Fall Rally Officially Begun?

Marijuana stocks soar off the bottom as investors eye the legalization of edibles, beverages, extracts, concentrates and topicals.

So far so good right? That’s what the majority of cannabis investors are thinking right now regarding the start of September trading. Historically cannabis stocks have performed extremely well this time of year, but will that trend continue in 2019?

Read full Legalization 2.0 article

Image Sourced from Pixabay

Related Articles

Cannabis Stock Gainers And Losers From January 20, 2021

GAINERS:  General Cannabis (OTCQB: CANN) shares closed up 26.92% at $0.83 read more

Cannabis Stock Gainers And Losers From January 14, 2021

GAINERS: Flower One Hldgs (OTCQX: FLOOF) shares closed up 37.3% at $0.21 read more

Cannabis Stock Gainers And Losers From January 13, 2021

GAINERS: Halo Labs (OTCQB: AGEEF) shares closed up 25% at $0.10 read more

Cannabis Analyst Reviews Sluggish Canadian Data: 'MSOs Will Outperform Again'

Hifyre Canadian cannabis sales data for the month of December is in, and the numbers suggest the Canadian retail cannabis market remains sluggish heading into 2021. read more